Navigation Links
Solta Medical and Alma Lasers Resolve Patent Lawsuits
Date:5/11/2010

HAYWARD, Calif. and Buffalo Grove, Ill., May 11 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), Alma Lasers Ltd. and Alma Lasers, Inc. today announced that they have reached an agreement resolving lawsuits involving certain Thermage® patents held by Solta Medical.

The lawsuit was originally filed on April 26, 2007 in the U.S. District Court in Delaware by Alma Lasers seeking a declaration that nine Thermage patents were invalid and not infringed.  Solta Medical filed counterclaims alleging that certain Alma systems for non-invasively treating skin infringed 11 of its patents, and sought damages and injunctive relief. The patents addressed in the lawsuit cover methods and devices for tightening skin and achieving other beneficial improvements in skin and tissue structures, all without damaging the skin surface. Alma subsequently filed counterclaims alleging that all 11 patents which were asserted were not infringed and were not valid.  

Terms of the Agreement

As a result of the agreement, Solta Medical and Alma are dismissing their respective litigation claims and have granted each other a covenant not to sue under certain of their respective patents and patent applications, including all the patents involved in the litigation. In addition, Alma paid Solta Medical a one time payment of $2.25 million. Solta Medical excluded from the covenant any rights to utilize monopolar RF which utilizes a passive return electrode. Additional terms of the settlement remain confidential.  

"We are pleased we were able to reach an amicable settlement while protecting our propriety position in monopolar technology, one of the key components used to create deep, uniform volumetric heating," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc.  "Solta Medical has invested more than 14 years developing, validating, and creating a strong IP portfolio and we will continue to invest in the scientific research needed to develop new, non-invasive aesthetic procedures."   Solta Medical currently holds 80 United States patents, and has additional patents issued and pending worldwide.  

Dr. Ziv Karni, President and Chief Executive Officer of Alma Lasers said, "We are delighted to have resolved our litigation with Solta Medical and to have obtained the covenant not to sue under Solta Medical's patents. We are also pleased that Solta Medical appreciated the value inherent in our BiPolar and UniPolar Radio Frequency technology and as a result we were able to mutually resolve our dispute. "

ABOUT SOLTA MEDICAL, INC.

Solta Medical is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's three premier brands: Thermage®, Fraxel® and Isolaz®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.solta.com.

ABOUT ALMA LASERS

Alma Lasers is a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications. Alma Lasers has been at the forefront of innovative multi-technology / multi-application systems designed to meet the unique needs of today's practitioners. Alma's mission is to provide modular, cost-effective and high-performance systems that enable practitioners to confidently offer safe, effective and profitable aesthetic treatments to their patients. For more information about Alma Lasers, please call 1-866-414-2562 or log on to www.almalasers.com.


'/>"/>
SOURCE Solta Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical to Participate in 2nd Annual Lazard Capital Markets Medical Technology Conference
2. Solta Medical, Inc. Announces Fourth Quarter 2009 Results Release Date and Conference Call
3. Solta Medical Donates Fraxel re:store(R) Laser System to Grossman Burn Foundation
4. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
5. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
6. Hothead Technologies Partners with Shafer Enterprises to Provide Break-Through Technology to Monitor and Manage Normothermia in Medical Patients
7. Inverness Medical Innovations to Present at the Bank of America Merrill Lynch 2010 Health Care Conference on May 11, 2010
8. Varian Medical Systems Equips Three Leading Cancer Centers in Istanbul with Advanced Radiotherapy Technology
9. Winner Medical Group Inc. to Attend the 2010 Brean Murray, Carret & Co. Life Sciences Summit in New York
10. Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT
11. Renhuang Elected as Deputy Chair Unit of Heilongjiang Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2017)...   OrthoAtlanta has been named the official orthopedic ... (AFHC) for the 2018 College Football Playoff (CFP) National Championship ... Stadium in Atlanta, Georgia . OrthoAtlanta is ... campaign, participating in many activities leading up to, and including ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... 2017 , ... The Davidson Institute for Talent Development will ... 27 at a reception in Washington D.C. The recipients received $50,000, $25,000 and ... “I am honored to be a Davidson Fellow Laureate,” said Rishab Gargeya, a ...
(Date:9/19/2017)... Brook, IL (PRWEB) , ... September 19, 2017 ... ... are significantly and positively linked to the Certified Emergency Nurse (CEN®) certification ... for Emergency Nursing (BCEN). The value of certification study, conducted by the Human ...
(Date:9/18/2017)... (PRWEB) , ... September 19, 2017 , ... ... Asia Pacific’s protein ingredient market , expected to grow at the fastest CAGR ... Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in Asia’ – ...
(Date:9/18/2017)... ... September 18, 2017 , ... ... the finance role on the executive team adding a Chief Financial Officer following ... independent company. This expansion will support the strategic growth strategy Aegis has defined ...
(Date:9/18/2017)... Fort Lee, NJ (PRWEB) , ... September 18, 2017 , ... ... state’s history, CareOne, a New jersey based company, has launched an aid effort focused ... Irma as it battered the state over two days and left thousands homeless and ...
Breaking Medicine News(10 mins):